Navigation Links
thrombolysis in Medical News

Dual treatment for stroke leads to improved recovery rates, reduced mortality

... that stroke patients who receive both intravenous thrombolysis a minimally invasive treatment that dissolves ... blocks an artery in the brain were treated with thrombolysis in combination with endovascular interventions, ... cohort of 30 consecutive patients treated with thrombolysis at a comparable facility where endovascular ...

Pharmacomechanical Thrombectomy Procedure Adoption to Accelerate Due to More Aggressive Treatment of Deep Vein Thrombosis, According to Millennium Research Group

... the ATTRACT (Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis) trial, which will compare catheter-directed thrombolysis (CDT) to PMT in the treatment of iliofemoral DVT, will not be completed until approximately 2014, early experience with PMT in this indication is ...

Telemonitoring changes the working practice of cardiac nurses

... traditional 'clot buster' treatment (thrombolysis) that has been the mainstay of hospital heart attack care for the past two decades. In some areas thrombolysis may be given by ambulance staff if travel times to a heart attack centre are likely to be very long, and research is continuing to identify the ...

Individualized stroke treatment available for patients, though underutilized

... blood clots. Strokes are the third leading cause of death in the U.S. and the most common cause of adult disability. To be effective, intravenous thrombolysis must be administered less than three hours after the onset of stroke symptoms. Unfortunately, and despite efforts to educate the public on the ...

Clot Dissolver Doesn't Boost Survival in Cardiac Arrest Patients

... emergency case systems, but only there." Now the researchers are devising possible new trials with variations on the theme. "We haven't used thrombolysis [clot-busting] in combination with an anticoagulant," a drug that prevents formation of clots, Böttiger mused. "We could try heparin or other ...

Research highlights new approaches to prevent blood clots

... Treatment typically consists of anticoagulants that help prevent clots from forming, medications that dissolve blood clots, catheter-directed thrombolysis (a surgical procedure where clot-dissolving medication is directed toward the blood clot), and thrombectomy, the surgical removal of a blood clot. ...

Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data

... C. Michael Gibson, M.S., M.D., principal investigator, chief of clinical research at the Beth Israel Deaconess Medical Center and director of the thrombolysis in Myocardial Infarction (TIMI) data coordinating center at Brigham and Women's Hospital, Boston, Mass. "We studied four different doses and ...

First Major Medical Meeting Convening for MRI-guided Focused Ultrasound to Treat Cancer, Stroke, Fibroids, Other Conditions

... Health Network, Toronto, Canada "This sort of focused meeting is how MRI started a generation ago. This could be as big or bigger. For stroke thrombolysis it could be the most important meeting in the country. The pieces are coming together for the breakthrough techniques of the next decade. MRgFUS 2008 ...

LA BioMed to honor 3 of its legendary

... than 20 grants and research awards to study new techniques for the treatment of intracranial aneurysms, arteriovenous malformations, cerebrovascular thrombolysis and angioplasty. In 1997, he was honored by the Joint Section of Cerebrovascular Surgery with a Lifetime Achievement Award. In 1999, he received ...

Heart and stroke death rates steadily decline; risks still too high

... the hospital quickly for the appropriate treatment is crucial to saving lives. We know that timely angioplasty to open blocked coronary arteries, or thrombolysis when primary angioplasty is not available or appropriate, is making a difference. The development of more hospitals into primary stroke centers and ...

More>>

thrombolysis in Medical Technology

Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study

... of safety and tolerability. TRA showed no increase in major and minor thrombolysis in Myocardial Infarction (TIMI)-scale bleeding when given with current ... for a minimum of one year. This Phase III trial is being conducted by the thrombolysis in Myocardial Infarction (TIMI) Study Group. The Phase III Thrombin ...

Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein

... successfully completed a proof-of-concept study in a non-human primate thrombolysis model that is expected to bear a close relationship with the future ... recently, a similar study with SMRX11, which Nostrum conducted in a canine thrombolysis model, has confirmed the results observed in the primate study. "We have ...

New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry

... and restores blood flow much quicker than the current catheter-directed thrombolysis (CDT) technique, which uses a drug alone and can take as long as two to ... 4: "An Endovascular Approach to Deep Venous Thrombosis Utilizing Isolated thrombolysis and Adjunctive Measures," can be found at http://www.SIRmeeting.org . ...

Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer

... Treatment typically consists of anticoagulants that help prevent clots from forming, medications that dissolve blood clots, catheter-directed thrombolysis (a surgical procedure where clot-dissolving medication is directed toward the blood clot), and thrombectomy, the surgical removal of a blood clot. ...

Pivotal National Trial Uses Newest Interventional Radiology Treatment to Bust Blood Clots in Legs

... is a multicenter, randomized trial "that will definitively determine if the newest clot-busting treatment (pharmacomechanical catheter-directed thrombolysis or PCDT) prevents post- thrombotic syndrome in patients with DVT," said Vedantham. PCDT combines the use of a clot-dissolving drug with a ...

Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel

... M.D., M.P.H., associate professor of medicine at Harvard Medical School and the Brigham and Women's Hospital, Boston, USA, and investigator with the thrombolysis in Myocardial Infarction (TIMI) Study Group. About TRITON-TIMI 38 TRITON-TIMI 38 was a Phase III, randomized, double-blind, head-to-head clinical ...

Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel

... sub-group analysis was presented today by Stephen Wiviott, M.D., Assistant Professor of Medicine at Harvard Medical School and investigator with the thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham & Women's Hospital, Boston, USA, at the Congress of the European Society of Cardiology (ESC) in ...

Is PCI Safe, Effective After Clot-Busters for Heart Attack?

... realistic goal," Dr. Cantor said. "If routine PCI is clearly superior to standard therapy in the TRANSFER-AMI trial, then all institutions that use thrombolysis for treating STEMI will need to develop strategies to get those patients to a cardiac catheterization laboratory within six hours." Dr. Cantor will ...

Trellis(R) Catheter Removes Blood Clots Quickly, Restoring Blood Flow in 771 Deep Vein Thrombosis (DVT) Patients

... up the blood clot in most patients in about 20 minutes. This technique restores blood flow more quickly and safely than current catheter-directed thrombolysis (CDT) techniques. It provides an important adjunct to the standard therapy of anti-coagulation alone, which is intended to prevent future clots but ...

SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients

... composite of cardiovascular death, MI or stroke. Patients will be followed for a minimum of one year. This Phase III trial is being conducted by the thrombolysis in Myocardial Infarction (TIMI) Study Group. The Phase III Thrombin Receptor Antagonist Clinical Event Reduction in acute coronary syndrome ...
thrombolysis in Medical Definition

Ultrasound-enhanced systemic thrombolysis

... Ultrasound-Enhanced Systemic thrombolysis is a medical technology. Researchers at the ... a technique called Ultrasound-Enhanced Systemic thrombolysis (transcranial doppler ultrasonography ) to treat ... External links Ultrasound-Enhanced Systemic thrombolysis for Acute Ischemic Stroke NEJM ...
thrombolysis in Biological News

Pivotal national trial uses newest interventional radiology treatment to bust blood clots in legs

... is a multicenter, randomized trial "that will definitively determine if the newest clot-busting treatment (pharmacomechanical catheter-directed thrombolysis or PCDT) prevents post-thrombotic syndrome in patients with DVT," said Vedantham. PCDT combines the use of a clot-dissolving drug with a ...
thrombolysis in Biological Technology

Chest Physicians Now Suggest Early Intervention for Certain Blood Clots in DVT

... cases of acute DVT with pharmacomechanical thrombolysis adds an important tool to help treat the acute ... suggesting the use of pharmacomechanical thrombolysis clearly establishes a new standard ... Vascular, Inc. Isolated pharmacomechanical thrombolysis using the Trellis Peripheral Infusion System from ...

New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome

... (ESC) Congress in Vienna, Austria. ExTRACT-TIMI 25 (Enoxaparin and thrombolysis Reperfusion for Acute Myocardial Infarction Treatment, thrombolysis in Myocardial Infarction -- Study 25) trial showed that in patients with ...

Major Medical Journal Reports Higher Success, Fewer Complications and Lower Cost Treating DVT With Trellis(R) Isolated Thrombolysis Compared With Catheter-Directed Thrombolysis

... (JVIR) has published a study comparing the clinical use of the Trellis-8 infusion catheter from Bacchus Vascular with conventional catheter-directed thrombolysis (CDT) in the treatment of DVT in its March 2008 issue. Results of the study showed that Grade II and III lysis was achieved in 93% of patients ...
Other Contents
(Date:9/30/2014)... Visit Pam and Steve’s quiet home in the ... a loving couple facing the most monumental challenge of ... Steve was diagnosed with ALS – more commonly known ... the couple’s second wedding anniversary. Pam is now ... “Care, Support & ALS,” that’s part of the ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 A highlight ... Optics (AMO) at the American Academy of Ophthalmology meeting ... LASIK surgeon Jeffrey Martin, MD on the ... is the Managing Partner of North Shore Eye Care ... SUNY Stony Brook. , This year’s 118th Annual American ...
(Date:9/30/2014)... News) -- Herceptin is the best drug treatment for ... remain the standard of care for that type of ... trial. HER2-positive breast cancers tend to be more ... the Mayo Clinic. For the study, more than ... or Tykerb (lapatinib) in addition to standard chemotherapy. ...
(Date:9/30/2014)... September 30, 2014 The St. Louis ... SLUCare Physician Group, comprised of more than 500 physicians, ... number of initiatives. With the recent addition of ... strengthening its market footprint to better respond to the ... , SLPA is a physician-led clinically integrated network (CIN) ...
(Date:9/30/2014)... Francisco, California (PRWEB) September 30, 2014 ... expected to reach USD 8,020.1 million by 2020, ... Research, Inc. Growing demand for personalized medicine and ... diagnostic technologies are expected to be key factors ... Moreover, the growing global base of geriatric population ...
Breaking Medicine News(10 mins):Health News:Hospice Provides Care and Support to Patients and Family Caregivers with ALS 2Health News:Global Laser Technology Leader Selects Jeffrey Martin, MD To Address Colleagues During International Symposium In Chicago 2014 2Health News:Global Laser Technology Leader Selects Jeffrey Martin, MD To Address Colleagues During International Symposium In Chicago 2014 3Health News:St. Louis Physician Alliance Expands Network and Market Footprint with Recent Addition of SLUCare Physician Group 2Health News:Global Molecular Diagnostics Market Is Expected To Be Worth $8,020.1 million by 2020: Grand View Research, Inc. 2Health News:Global Molecular Diagnostics Market Is Expected To Be Worth $8,020.1 million by 2020: Grand View Research, Inc. 3Health News:Global Molecular Diagnostics Market Is Expected To Be Worth $8,020.1 million by 2020: Grand View Research, Inc. 4Health News:Global Molecular Diagnostics Market Is Expected To Be Worth $8,020.1 million by 2020: Grand View Research, Inc. 5Health News:Global Molecular Diagnostics Market Is Expected To Be Worth $8,020.1 million by 2020: Grand View Research, Inc. 6
(Date:9/29/2014)... species of gut bacteria called Clostridium ramosum , coupled ... The work is published this week in mBio , ... , A research team from the German Institute of ... gut bacteria including C. ramosum gained weight when ... C. ramosum were less obese even when consuming a ...
(Date:9/29/2014)... WASHINGTON, DC September 29, 2014 -- Plants ... ,commensal, bacteria help the pants extract nutrients and ... preventing pathogens from contaminating fruits and vegetables. Now, ... commensal bacteria inside of seeds; thus ensuring that ... researchers, from the University of Notre Dame, presented ...
(Date:9/29/2014)... NASA story from 2009, "human activities in this area of ... Palm oil is increasingly grown for use as a cooking ... foods. It has become the most widely produced edible oil ... to surpass that of soybean oil. , The environmental effects ... cleared to grow the crop, and the preferred method is ...
Breaking Biology News(10 mins):Gut bacteria promote obesity in mice 2Plants prepackage beneficial microbes in their seeds 2
Other TagsOther Tags